Brief: Bolt Biotherapeutics To Present Interim Clinical Data On BDC-1001 Phase 1/2 Clinical Trial

Bolt Biotherapeutics

02/12/2021 11:36

Dec 2 (Reuters) - Bolt Biotherapeutics Inc  BOLT.O :
    * BOLT BIOTHERAPEUTICS TO PRESENT INTERIM CLINICAL DATA ON
BDC-1001 PHASE 1/2 CLINICAL TRIAL AT ESMO IMMUNO-ONCOLOGY
CONGRESS 2021

Source text for Eikon:  ID:nGNX50DRLq 
Further company coverage:  BOLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))